Chargement en cours...
Optimized TrkB Agonist Ameliorates Alzheimer’s Disease Pathologies and Improves Cognitive Functions via Inhibiting Delta-Secretase
[Image: see text] BDNF/TrkB neurotropic pathway, essential for neural synaptic plasticity and survival, is deficient in neurodegenerative diseases including Alzheimer’s disease (AD). Our previous works support that BDNF diminishes AD pathologies by inhibiting delta-secretase, a crucial age-dependent...
Enregistré dans:
| Publié dans: | ACS Chem Neurosci |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Chemical Society
2021
|
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8269693/ https://ncbi.nlm.nih.gov/pubmed/34106682 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acschemneuro.1c00181 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|